OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
Maria Krutikov, Tom Palmer, Gokhan Tut, et al.
The Lancet Healthy Longevity (2021) Vol. 3, Iss. 1, pp. e13-e21
Open Access | Times Cited: 80
Maria Krutikov, Tom Palmer, Gokhan Tut, et al.
The Lancet Healthy Longevity (2021) Vol. 3, Iss. 1, pp. e13-e21
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
EBioMedicine (2022) Vol. 78, pp. 103938-103938
Open Access | Times Cited: 54
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
EBioMedicine (2022) Vol. 78, pp. 103938-103938
Open Access | Times Cited: 54
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 5, pp. e347-e355
Open Access | Times Cited: 46
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 5, pp. e347-e355
Open Access | Times Cited: 46
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort
Annalan M D Navaratnam, Madhumita Shrotri, Vincent Nguyen, et al.
International Journal of Infectious Diseases (2022) Vol. 123, pp. 104-111
Open Access | Times Cited: 39
Annalan M D Navaratnam, Madhumita Shrotri, Vincent Nguyen, et al.
International Journal of Infectious Diseases (2022) Vol. 123, pp. 104-111
Open Access | Times Cited: 39
Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers
Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs
Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 7
Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 7
Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies
Yu Nakagama, Yuko Komase, Natsuko Kaku, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 30
Yu Nakagama, Yuko Komase, Natsuko Kaku, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 30
Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update
Adam H. Dyer, Aoife Fallon, Claire Noonan, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 9, pp. 1590-1602
Open Access | Times Cited: 27
Adam H. Dyer, Aoife Fallon, Claire Noonan, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 9, pp. 1590-1602
Open Access | Times Cited: 27
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Gokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Nature Aging (2023) Vol. 3, Iss. 1, pp. 93-104
Open Access | Times Cited: 17
Gokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Nature Aging (2023) Vol. 3, Iss. 1, pp. 93-104
Open Access | Times Cited: 17
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern
Jinal N. Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jinal N. Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
Gokhan Tut, Tara Lancaster, Panagiota Sylla, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 7, pp. e461-e469
Open Access | Times Cited: 25
Gokhan Tut, Tara Lancaster, Panagiota Sylla, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 7, pp. e461-e469
Open Access | Times Cited: 25
The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center
Agata Skrzat‐Klapaczyńska, Carlo Bieńkowski, Justyna D. Kowalska, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 552-552
Open Access | Times Cited: 22
Agata Skrzat‐Klapaczyńska, Carlo Bieńkowski, Justyna D. Kowalska, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 552-552
Open Access | Times Cited: 22
Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI)
Oliver Stirrup, Gokhan Tut, Maria Krutikov, et al.
Wellcome Open Research (2024) Vol. 9, pp. 45-45
Open Access | Times Cited: 4
Oliver Stirrup, Gokhan Tut, Maria Krutikov, et al.
Wellcome Open Research (2024) Vol. 9, pp. 45-45
Open Access | Times Cited: 4
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients
Yael Einbinder, Jeffrey Perl, Naomi Nacasch, et al.
American Journal of Nephrology (2022) Vol. 53, Iss. 7, pp. 586-590
Open Access | Times Cited: 20
Yael Einbinder, Jeffrey Perl, Naomi Nacasch, et al.
American Journal of Nephrology (2022) Vol. 53, Iss. 7, pp. 586-590
Open Access | Times Cited: 20
B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV ‐2 vaccine efficacy in anti‐CD20 ‐treated multiple sclerosis patients
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3317-3328
Open Access | Times Cited: 18
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3317-3328
Open Access | Times Cited: 18
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada
Jessica A. Breznik, Ahmad Rahim, Tara Kajaks, et al.
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 5, pp. 753-758
Open Access | Times Cited: 11
Jessica A. Breznik, Ahmad Rahim, Tara Kajaks, et al.
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 5, pp. 753-758
Open Access | Times Cited: 11
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study
Jelena Bešević, Ben Lacey, Howard Callen, et al.
Journal of Epidemiology & Community Health (2023) Vol. 78, Iss. 2, pp. 105-108
Open Access | Times Cited: 11
Jelena Bešević, Ben Lacey, Howard Callen, et al.
Journal of Epidemiology & Community Health (2023) Vol. 78, Iss. 2, pp. 105-108
Open Access | Times Cited: 11
Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States
James M. Haynes, Roger Y. Dodd, Lauren A. Crowder, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 7
Open Access | Times Cited: 9
James M. Haynes, Roger Y. Dodd, Lauren A. Crowder, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 7
Open Access | Times Cited: 9
Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection
Verena Nunhofer, Lisa Weidner, Alexandra Domnica Hoeggerl, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 637-637
Open Access | Times Cited: 14
Verena Nunhofer, Lisa Weidner, Alexandra Domnica Hoeggerl, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 637-637
Open Access | Times Cited: 14
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
Gro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Gro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
